What Causes Overweight or Obesity
CHAKRABARTI: So Professor Holst, I wanted to ask you about this because there do seem to be the spectrum of intensity of side effects for these GLP-1 seems to be quite large, and the more and more people who come on it or who go on it and with staying on it for a longer period of time, are you concerned that we may start seeing side effects that are so severe that it would cast some doubt on the efficacy of GLP-1s
In the DURATION-8 study, the SGLT2i dapagliflozin was used in combination therapy with exenatide and showed reductions in HbA1c, systolic blood pressure, and blood glucose, with improved weight loss, when compared to monotherapy [93]
Understanding this connection can transform how you approach your meals and support your health goals
By dampening the VTA, GLP-1s subtly influence you to eat less by making it seem less rewarding to eat, even when youre not hungry
Se debe supervisar la respuesta y suspender el tratamiento si no hay reduccin del 1% en la HbA1c o del 3% del peso en 3-6 meses
